Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Na
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Head and Neck Cancer - Lymphoma - Nausea and Vomiting - Neuroblastoma - Ovarian Cancer - Sarcoma
1 Location available
- Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
1 Location available
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Conditions: Kidney Cancer - Leukemia - Lymphoma - Myelodysplastic Syndromes - Neuroblastoma - Pulmonary Complications - Sarcoma
38 Locations available
- A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
Conditions: Peripheral T-Cell Lymphoma
1 Location available
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphob
Conditions: Kidney Cancer - Leukemia - Lymphoma - Neurotoxicity - Peripheral Neuropathy - Sarcoma
44 Locations available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
172 Locations available
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hem
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- Rituximab and Pegfilgrastim in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
Conditions: AIDS Related Lymphoma - HIV Infection
1 Location available
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
2 Locations available
- Antiretroviral Therapy With or Without Bortezomib or Combination Chemotherapy and Rituximab or Sirolimus Only or Observation Only in Treating Patients
Conditions: Lymphoma - Precancerous Condition - Sarcoma
2 Locations available
- Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma
3 Locations available
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
227 Locations available
- Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Conditions: AIDS-Related Primary Central Nervous System Lymphoma - HIV
1 Location available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
Conditions: Hodgkin's Lymphoma
5 Locations available
- Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Conditions: Lymphoma, Non-Hodgkin - Hodgkin's Disease
1 Location available
- Bevacizumab and Bortezomib in Patients With Advanced Malignancy
Conditions: Advanced Malignancy - Lymphoma - Myeloma - Solid Tumors
1 Location available
- Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma - Lymphoma
2 Locations available
- Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Conditions: Hodgkin's Disease
1 Location available
- Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoblastic Lymphoma - Leukemia, Lymphoblastic, Acute
1 Location available
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
Conditions: Lymphoma - Bone Marrow Transplantation
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer - Brain Cancer - Breast Cancer - CNS Cancer - Colon Cancer - HEENT Cancer - Hodgkin's Disease - Kaposi's Sarcoma - Liver Cancer - Lung Cancer - Non-Hodgkin's Lymphoma - Ovarian Cancer - Pancreatic Cancer - Prostate Cancer - Rectal
1 Location available
- CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia
Conditions: Lymphoma - Leukemia
3 Locations available
- Stem Cell Transplantation To Treat High Risk Lymphoid Diseases With Reduced Toxicity Myeloablative Conditioning Regimen
Conditions: Multiple Myeloma - Plasma Cell Leukemia - Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Precancerous Condition
2 Locations available
- Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Conditions: Leukemia - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Burkitt Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma -
2 Locations available
- T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Disease - Leukemia, Lymphocytic, Chronic - Lymphoproliferative Disorders
1 Location available
- Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
Conditions: Non-Hodgkin's Lymphoma
4 Locations available
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lym
Conditions: Leukemia - Lymphoma
1 Location available
- Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Lymphoma
1 Location available
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Conditions: Lymphoma
1 Location available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic -
4 Locations available
- Studying Patients With a Personal or Family History of Cancer Caused by a Virus
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Sarcoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating P
Conditions: Graft Versus Host Disease - Leukemia - Lymphoma
1 Location available
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Conditions: Breast Neoplasms - Ovarian Neoplasms - Colonic Neoplasms - Prostatic Neoplasms - Uterine Cervical Neoplasms - Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Systemic Anaplastic Large-Cell Lymphoma - Neoplasms - Anaplastic Lymphoma Kinase, Human
9 Locations available
- A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy
Conditions: Cancer - Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
5 Locations available
- Biological Therapy and Combination Chemotherapy in Treating Patients With Lymphomatoid Granulomatosis
Conditions: Lymphoma - Precancerous Condition
2 Locations available
- Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Mycosis Fungoides/Sezary Syndrome
Conditions: Lymphoma
1 Location available
- Fludarabine, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk C
Conditions: B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia - T-cell Large Granular Lymphocyte Leukemia
2 Locations available
- Rituximab&Methotrexate Chemotherapy w/BBBD & Sodium Thiosulfate Chemoprotection for Patients With Newly Diagnosed PCNSL
Conditions: Brain and Central Nervous System Tumors - Lymphoma
2 Locations available
- Safety Study of Injections of Autologous/Allogeneic TGFbeta-resistant LMP2A-specific Cytotoxic T-lymphocytes (CTL)
Conditions: RELAPSED EBV-POSITIVE LYMPHOMA
3 Locations available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Conditions: Lymphoma
1 Location available
- Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Adults - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Metastatic Cancer - Neurofibromatosis Type
1 Location available
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Pati
Conditions: Lymphoma, B-Cell
1 Location available
- GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Conditions: Lymphoma
1 Location available
- Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Conditions: Lymphoma
41 Locations available
- T-Reg Cell Kinetics for Patients Receiving Stem Cell Transplant
Conditions: Leukemia - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Myelodysplastic Disease - Myeloproliferative Disorders
3 Locations available
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgk
Conditions: Lymphoma
12 Locations available
- Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Conditions: Diffuse, Large B-Cell, Lymphoma
1 Location available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
17 Locations available
- Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Conditions: Leukemia, Myelogenous, Chronic - Leukemia, Lymphoblastic, Acute - Leukemia, Myelogenous, Acute - Myeloproliferative-Myelodysplastic Diseases - Lymphoma, Malignant
1 Location available
- Genetic Epidemiology of Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin - Leukemia, Lymphocytic, Chronic, B-Cell - Lymphoma, B-Cell
1 Location available
- Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
Conditions: Burkitt's Lymphoma - Burkitt'S-like Lymphoma
1 Location available
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for R
Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma - Monocytoid B-cell Lymphoma - Recurrent Adult Burkitt's Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
1 Location available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Blood and Tissue Collection for Cutaneous Lymphoma Research
Conditions: Cutaneous T-Cell Lymphoma - Sezary Syndrome - Mycosis Fungoides
1 Location available
- Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
4 Locations available
- Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Conditions: Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Conditions: B-Cell Lymphoma
1 Location available
- Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Conditions: Lymphoma
1 Location available
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Cyclophosphamide, Fludarabine, Total-Body Irradiation, and Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer or Other
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Conditions: Lymphoma
1 Location available
- Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Intensity-Modulated Radiation Therapy, Fludarabine, and Melphalan Followed by a Donor Stem Cell Transplant in Treating Patients With Hematological Can
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
Conditions: Leukemia - Lymphoma
1 Location available
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Lung Cancer - Melanoma - Non-Hodgkin's Lymphoma - Uterine Cancer - CORPUS UTERI,ENDOMETRIUM - LUNG - OVARY
1 Location available
- Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Conditions: Hodgkin's Disease - Non Hodgkin's Lymphoma - Myeloma - Leukemia - Myelodysplasia
1 Location available
- A Phase I/II Trial of VR-CHOP in Lymphoma Patients
Conditions: Lymphoma, B-Cell - Follicular Lymphoma
1 Location available
- Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell
Conditions: Hodgkin's Disease - Lymphoma
4 Locations available
- Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Conditions: Non Hodgkin's Lymphoma
1 Location available
- Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders - Lymphoma
1 Location available
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Follicular
14 Locations available
- Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma
Conditions: Cancer - Lymphomas
1 Location available
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies - Acute Myeloid Leukemia - Lymphoid Leukemia - Chronic Myeloid Leukemia - Hodgkin's Disease - Non-Hodgkin's Lymphoma - Myelodysplastic Syndromes
12 Locations available
- Low Dose IL-2 for GVHD as GVHD Prophylaxis After Stem Cell Transplantation
Conditions: Leukemia - Lymphoma
2 Locations available
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL) - Leukemia, Myeloid, Acute(AML) - Leukemia, Myeloid, Chronic(CML) - Juvenile Myelomonocytic Leukemia (JMML) - Hemoglobinuria, Paroxysmal Nocturnal (PNH) - Hodgkin Lymphoma - Lymphoma, Non-Hodgkin (NHL) - Myelodysplastic S
1 Location available
- Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Conditions: Lymphoma
1 Location available
- Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Conditions: Lymphoma - Leukemia - Multiple Myeloma - Colon Cancer - Renal Cancer
1 Location available
- CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
3 Locations available
- Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinic
Conditions: Aids-related Malignancies - Lymphoma - Precancerous Condition - Sarcoma
7 Locations available
- Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma - Chronic Lymphocytic Leukemia
3 Locations available
- Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma
Conditions: Lymphoma, Non-Hodgkin - Hodgkin Disease
1 Location available
- Oblimersen Sodium and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Diffuse Large B-Cel
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage I Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
2 Locations available
- Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Other Hematological Disorders - Metabolic Storage Diseases
17 Locations available
- Lymphoma Follow-up
Conditions: Lymphoma
1 Location available
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoma, Lymphoblastic
2 Locations available
- A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma
Conditions: Central Nervous System Lymphoma - Intraocular Lymphoma
1 Location available
- Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- Topical Romidepsin in Treating Patients With Stage I or Stage II Cutaneous T-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Conditions: Lymphoma, Mantle-Cell
1 Location available
- Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
Conditions: Lymphoma
1 Location available
- Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
Conditions: Leukemia - Cancer - Lymphoma
2 Locations available
- Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
2 Locations available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
9 Locations available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors
Conditions: Primary Central Nervous System Lymphoma (PCNSL)
1 Location available
- Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
Conditions: Lymphoma
3 Locations available
- Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
2 Locations available
- A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bor
Conditions: Mantle Cell Lymphoma
26 Locations available
- Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Conditions: Non-hodgkins Lymphoma - Hodgkins Lymphoma - Multiple Myeloma
1 Location available
- Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Conditions: Hodgkin's Lymphoma
1 Location available
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation - Leukemia - Lymphoma
1 Location available
- Sitagliptin Umbilical Cord Blood Transplant Study
Conditions: Leukemia, Myeloid, Acute - Acute Lymphoblastic Leukemia - Myelodysplasia - Leukemia, Myelogenous, Chronic - Lymphoma, Non-Hodgkin
1 Location available
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-Cell Lymphoma
Conditions: Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell
1 Location available
- A Phase II Study of Umbilical Cord Blood Transplantation
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Aplastic Anemia
1 Location available
- Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse La
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cel
1 Location available
- A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
Conditions: Brain Tumors - Leukemia - Sarcomas - Neuroblastoma - Lymphoma - Hodgkins Disease
1 Location available
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
4 Locations available
- Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
4 Locations available
- Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lympho
Conditions: Leukemia - Lymphoma
2 Locations available
- Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
1 Location available
- Evaluate Rituximab in Obtaining PCR Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma
Conditions: Non-Hodgkins Lymphoma
2 Locations available
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Dis
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
1 Location available
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic
Conditions: Lymphoma, Mantle-Cell - Leukemia, Lymphocytic, Chronic, B-Cell - Leukemia, Hairy Cell - Waldenstrom Macroglobulinemia - Multiple Myeloma
1 Location available
- Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
Conditions: Lymphoma
1 Location available
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer - Hypercalcemia of Malignancy - Colon Cancer - Endocrine Cancer - Head and Neck Cancer - Kidney Cancer - Lung Cancer - Lymphoma - Metastatic Cancer - Multiple Myeloma - Parathyroid Neoplasms - Renal Cancer - Thyroid Cancer - Hodgkin's Lympho
10 Locations available
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
140 Locations available
- Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma
Conditions: Lymphoma - Hodgkin Disease - Lymphoma, Non-Hodgkin
1 Location available
- Pilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's Lymphoma
Conditions: Hodgkin's Lymphoma
1 Location available
- Natural History Study of Monoclonal B Cell Lymphocytosis and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: B-Cell Chronic Lymphocytic Leukemia - Monoclonal B-Cell Lymphocytosis - Lymhoma, Small Lymphocytic - Chronic Lymphocytic Leukemia
1 Location available
- Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or
Conditions: Lymphoma
3 Locations available
- Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa
1 Location available
- T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia - Lymphoid Leukemia - Chronic Myelogenous Leukemia - Malignant Lymphoma - Hodgkin's Disease - Chronic Lymphocytic Leukemia - Myeloproliferative Disorder - Anemia, Aplastic - Myelodysplastic Syndromes
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan With or Without Rituximab, Combination Chemotherapy, and an Autologous Stem Cell Transplant in Treating Patients Wit
Conditions: Lymphoma
1 Location available
- Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Any Solid Tumor or Lymphoma
1 Location available
- Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
Conditions: Lymphoma - Hodgkin Disease - Lymphoma, Non-Hodgkin
7 Locations available
- Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
Conditions: Leukemia - Myelodysplastic Syndrome - Non-Hodgkins Lymphoma - Chronic Myelogenous Leukemia
1 Location available
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
4 Locations available
- Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Conditions: Relapsed Lymphomas - Refractory Lymphomas
1 Location available
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Conditions: MDS - Leukemias - Lymphomas
2 Locations available
- Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Di
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
2 Locations available
- Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment
Conditions: Lymphoma
1 Location available
- Studying Fentanyl in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pr
1 Location available
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
Conditions: Central Nervous System Lymphoma
2 Locations available
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage I Chronic Lymphocytic Leukemia - Stage I Small Lymphocytic Lymphoma - Stage II Chronic Lymphocytic Leukemia -
2 Locations available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
Conditions: Multiple Myeloma - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - Non Hodgkin's Lymphoma - Waldenstroms - Mantle Cell Lymphoma
1 Location available
- Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine
Conditions: Mantle Cell Lymphoma
9 Locations available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
Conditions: Lymphoma
1 Location available
- Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy
Conditions: Non-Hodgkin's Lymphoma
2 Locations available
- Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
Conditions: Lymphoma
2 Locations available
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
1 Location available
- DT2219ARL Immunotoxin in Treating Patients With B-Cell Leukemia or Lymphoma That Has Relapsed or Not Responded to Treatment
Conditions: Leukemia - Lymphoma
3 Locations available
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Plasma Cell Neoplasm - Myelodysplastic Syndromes
4 Locations available
- Acupuncture for Chemo-Induced Peripheral Neuropathy
Conditions: Lymphoma - Myeloma - Peripheral Neuropathy
1 Location available
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Conditions: Mycoses - Sezary Syndrome - Lymphoma, T-Cell, Cutaneous - Bone Marrow Transplant Failure - Lymphoma, Non-Hodgkin - Cutaneous T-cell Lymphoma of Skin
1 Location available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
2 Locations available
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
1 Location available
- Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
1 Location available
- Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
Conditions: Lymphoma
2 Locations available
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia - Lymphoma, Non-Hodgkin - Hodgkin Disease - Myelodysplastic Syndromes - Multiple Myeloma
1 Location available
- Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapse
Conditions: Leukemia - Lymphoma
1 Location available
- Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin
1 Location available
- A Study of MLN9708 in Adult Patients With Lymphoma
Conditions: Lymphoma
4 Locations available
- A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Al
Conditions: Non-hodgkin Lymphoma - Hodgkin Lymphoma
2 Locations available
- An SGN-35 Trial for Patients Who Have Previously Participated in an SGN-35 Study
Conditions: Disease, Hodgkin - Lymphoma, Large-Cell, Anaplastic - Lymphoma, Non-Hodgkin
15 Locations available
- PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
Conditions: Lymphoma
34 Locations available
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
Conditions: Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage I Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-cell Non-Hodgkin Lymphoma - Stage II Mycosis Fungoides/Sezary Syndrome - Stage III Cutaneous T-cell Non-Hodgkin Lymphoma - Stage III Mycosis F
1 Location available
- Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk He
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Myelodysplastic Syndromes
1 Location available
- Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
Conditions: Lymphoma
1 Location available
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
20 Locations available
- 124I-FIAU Imaging in EBV and KSHV Associated Cancers
Conditions: Hodgkin Lymphoma - Non Hodgkin Lymphoma - Kaposi's Sarcoma - Gastric Cancer - Nasopharyngeal Cancer
1 Location available
- Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantat
Conditions: Hodgkin's Lymphoma - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemias - Multiple Myeloma With Plasmacytoma
1 Location available
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Leukemia - Lymphoma - Allogeneic Haematopoietic Stem Cell Transplantation - Acute Lymphoblastic Leukemia
1 Location available
- R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
Conditions: Hodgkin Lymphoma
1 Location available
- Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma - Contiguous Stage II Grade 1 Follicular Lymphom
1 Location available
- Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL
Conditions: Chronic Lymphocytic Lymphoma
1 Location available
- T-Lymphocytes in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma
3 Locations available
- Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab
Conditions: Lymphocytic Leukemia - Mantle Cell Lymphoma
1 Location available
- Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred
Conditions: Hodgkin's Disease - Non-Hodgkin's Lymphoma
1 Location available
- Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
7 Locations available
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Conditions: Non-Hodgkin's Lymphoma - Leukemia - Multiple Myeloma - Myeloproliferative Disorder
1 Location available
- Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
Conditions: Hematologic Malignancies, Multiple Myeloma, Lymphoma
2 Locations available
- FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Conditions: Lymphoma
144 Locations available
- Siplizumab, Combination Chemotherapy, and Rituximab in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
2 Locations available
- Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-H
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
Conditions: Lymphoblastic Leukemia - Lymphoblastic Lymphoma
1 Location available
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
138 Locations available
- Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Lymphoblastic Leukemia - Acute Leukemia - Non Hodgkins Lymphoma - Chronic Myeloid Leukemia
1 Location available
- Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage 0 Chronic Lymphocytic Leukemia - Stage I Chronic Lymphocytic Leukemia - Stage
4 Locations available
- Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
Conditions: Multiple Myeloma - Non-Hodgkins Lymphoma
1 Location available
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Conditions: 714leukemia - Lymphoma
1 Location available
- Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Conditions: T Cell Non-Hodgkin Lymphoma
1 Location available
- Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom
Conditions: Lymphoma
1 Location available
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
44 Locations available
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
420 Locations available
- Methionine PET/CT Studies In Patients With Cancer
Conditions: Brain Tumors and /or Solid Tumors Including: - Brain Stem Glioma - High Grade CNS Tumors - Ependymoma - Medulloblastoma - Craniopharyngioma - Low Grade CNS Tumors - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Ewing Sarcoma - Osteosarcoma - Rhabdomyosarcoma
1 Location available
- Proton Therapy for Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma
1 Location available
- Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
Conditions: Cutaneous T-Cell Lymphoma
1 Location available
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
176 Locations available
- Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Conditions: Mantle Cell Lymphoma - Lymphoma
1 Location available
- T-cell Depleted Alternative Donor Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Lymphomas - Pancytopenia - Hemoglobinopathy - Immune Deficiency - Osteopetrosis
1 Location available
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
37 Locations available
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
10 Locations available
- Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent
Conditions: Solid Tumors - Lymphoma
2 Locations available
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Ho
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Chronic Lymphocytic Leukemia - Burkitt Lymphoma - Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymp
2 Locations available
- Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Conditions: Lymphoma
21 Locations available
- Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
Conditions: Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - Leukemia, Myelocytic, Acute - Leukemia, Myeloid, Chronic - Lymphoma, Non-Hodgkin - Lymphoma, Hodgkins
1 Location available
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
Conditions: Unspecified Childhood Solid Tumor, Protocol Specific - Accelerated Phase Chronic Myelogenous Leukemia - Acute Undifferentiated Leukemia - Angioimmunoblastic T-cell Lymphoma - Atypical Chronic Myeloid Leukemia - Blastic Phase Chronic Myelogenous Leukemia -
1 Location available
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Ind
Conditions: Non-Hodgkin's Lymphoma
32 Locations available
- Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)
Conditions: Solid Tumors - Lymphoma, Non-Hodgkin - Multiple Myeloma - Leukemia, Lymphocytic, Chronic. B-Cell
1 Location available
- Pilot Study for Patients With Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma
Conditions: Acute Lymphocytic Leukemia - Follicular Lymphoma - Chronic Lymphocytic Leukemia (CLL) - Mantle Cell Lymphoma - Prolymphocytic Leukemia - Large Cell Lymphoma
1 Location available
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Conditions: Leukemia - Lymphoma - Myeloma
1 Location available
- SCRI TISSUE TESTING REGISTRY
Conditions: Melanoma - Myelodysplastic Syndrome - Multiple Myeloma - Lymphoma
1 Location available
- Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Trea
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Chronic Lymphocytic Leukemia - Myelodysplasia - Non-Hodgkin's Lymphoma - Hodgkin's Disease - Multiple Myeloma - Myelofibrosis - Anemia, Aplastic - Hemoglobinuria, Par
1 Location available
- 5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Conditions: Advanced Cancer - Solid Tumor - Lymphoma
1 Location available
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
8 Locations available
- Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-cell Lymphoma - Nodal Marginal Zone B-ce
2 Locations available
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, Follicular
6 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Conditions: Hairy Cell Leukemia (HCL) - Chronic Lymphocytic Leukemia (CLL) - Non-Hodgkins Lymphoma (NHL) - Cutaneous T Cell Lymphoma (CTCL) - Adult T Cell Lymphoma (ATL)
1 Location available
- Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
Conditions: Lymphoma
12 Locations available
|